Effect of hypo- and hyperkalemia on mode of death in patients with heart failure following myocardial infarction

被引：0
|
作者：
Kjekshus, J
Snappin, S
Hognestad, A
Dickstein, K
机构：
[1] Natl Hosp Norway, Dept Cardiol, Oslo, Norway
[2] Merck Sharp & Dohme Ltd, Res Labs, W Point, PA 19486 USA
[3] Aker Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway
[4] Cent Hosp Rogaland, Dept Med, Stavanger, Norway
来源：
EUROPEAN HEART JOURNAL | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [21] Thyroid dysfunction and heart failure: no specific echocardiographic pattern for hypo- and hyperthyroidism
    Frigy, A.
    Nistor, D.
    Kocsis, I.
    Fehervari, L.
    Carasca, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 273 - 273
  • [22] Risk of Acute Myocardial Infarction, Heart Failure, and Death in Migraine Patients Treated with Triptans
    Ghanshani, Serena
    Chen, Cheng
    Lin, Bryan
    Duan, Lewei
    Shen, Yuh-Jer Albert
    Lee, Ming-Sum
    HEADACHE, 2020, 60 (10): : 2166 - 2175
  • [23] Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
    Solomon, SD
    Zelenkofske, S
    McMurray, JJV
    Finn, PV
    Velazquez, E
    Ertl, G
    Harsanyi, A
    Rouleau, JL
    Maggioni, A
    Kober, L
    White, H
    Van de Werf, F
    Pieper, K
    Califf, RM
    Pfeffer, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25): : 2581 - 2588
  • [24] Mode of death in patients with systolic heart failure
    Patel, Jigar
    Heywood, J. Thomas
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 12 (02) : 127 - 136
  • [25] Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure
    Ahmad, Tariq
    Fiuzat, Mona
    Neely, Benjamin
    Neely, Megan L.
    Pencina, Michael J.
    Kraus, William E.
    Zannad, Faiez
    Whellan, David J.
    Donahue, Mark P.
    Pina, Ileana L.
    Adams, Kirkwood F.
    Kitzman, Dalane W.
    O'Connor, Christopher M.
    Felker, G. Michael
    JACC-HEART FAILURE, 2014, 2 (03) : 260 - 268
  • [26] EFFECT OF NISOLDIPINE ON EXERCISE PERFORMANCE IN HEART-FAILURE FOLLOWING MYOCARDIAL-INFARCTION
    LEWIS, BS
    MAKHOUL, N
    MERDLER, A
    FLUGELMAN, MY
    FRONT, A
    HARDOFF, R
    HALON, DA
    CARDIOLOGY, 1991, 79 (01) : 39 - 45
  • [27] Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction
    Wada, K
    Tahara, A
    Arai, Y
    Aoki, M
    Tomura, Y
    Tsukada, J
    Yatsu, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (02) : 169 - 177
  • [28] Predictors of sudden death in patients following myocardial infarction
    Boldoueva, S
    Shabrov, A
    Zhuk, V
    Samokhvalova, M
    Leonova, I
    Burak, T
    EUROPACE 2001, 2001, : 573 - 577
  • [29] Efficacy of sacubitril/ valsartan in patients with heart failure following right ventricular myocardial infarction
    Stepanyan, A. Anna
    Hayrapetyan, H.
    Petrosyan, H.
    Safaryan, M.
    Poghosyan, H.
    Meloyan, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 225 - 225
  • [30] Clinical modifiers for heart failure following myocardial infarction.
    Anavekar N.S.
    Anavekar N.S.
    Current Heart Failure Reports, 2005, 2 (4) : 165 - 173
12345